Holdings
Armistice Capital, LLC
As of Sep 30, 2026, Armistice Capital, LLC reported 298 positions worth US$2.95B. Largest: Supernus Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc. and PTC Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2.55M | US$110M | −98,201 | Sep 30, 2026 |
| Agios Pharmaceuticals, Inc. | 2.58M | US$85.7M | +178K | Sep 30, 2026 |
| PTC Therapeutics, Inc. | 1.3M | US$84.1M | +226K | Sep 30, 2026 |
| Neurocrine Biosciences, Inc. | 565K | US$80.2M | +29,413 | Sep 30, 2026 |
| Cytokinetics, Incorporated | 1.18M | US$77.8M | −21,150 | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 1.29M | US$75.9M | −283K | Sep 30, 2026 |
| Rigel Pharmaceuticals, Inc. | 1.54M | US$74M | −136K | Sep 30, 2026 |
| Incyte Corporation | 600K | US$72.8M | −300K | Sep 30, 2026 |
| Ironwood Pharmaceuticals, Inc. | 15M | US$59.5M | +1.07M | Sep 30, 2026 |
| Immunovant, Inc. | 1.74M | US$58.7M | +2,169 | Sep 30, 2026 |